Skip to main content


Emerging technology would improve diagnosis, treatment of eye disorders


Biomedical engineering researchers at Arizona State University are working with an industry partner to advance development of technology enabling the use of tear fluid samples to diagnose and monitor people’s health. Advanced Tear Diagnostics, a medical products company based in Birmingham, Ala., is providing funding and technical support for research led by Jeffrey La Belle to improve and expand the use of tear fluid as a biomarker to detect various ocular (eye) disorders.